Skip to main content

Table 1 Basic patient characteristics

From: Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification

Variable N = 100
Age (mean ± SD) (year) 65.1 ± 11.2
BMI (m2/kg) 23.56 ± 5.93
Gender
 Female 17 (17.0%)
 Male 83 (83.0%)
ASA
 1 34 (34.0%)
 2 57 (57.0%)
  ≥ 3 9 (9.0%)
pT stage
 T2 50 (50.0%)
 T3 42 (42.0%)
 T4 8 (8.0%)
 LVI 42 (42.0%)
 CIS 34 (34.0%)
N stage
 N0 80 (80.0%)
 N1 7 (7.0%)
 N2 8 (8.0%)
 N3 5 (5.0%)
LND range
 Standard 36 (36.0%)
 Extend 64 (64.0%)
Removed LN 14.1 ± 12.9
Positive LN 1.0 ± 2.8
Recurrence 31 (31.0%)
Mortality 59 (59.0%)
Cancer related mortality 32 (32.0%)
  1. BMI Body mass index, LVI Lymphovascular invasion, CIS Carcinoma in situ, LND Lymph node dissection, LN Lymph node;